2025 Agenda

Wednesday, October 15

Time

Event

8:00 am – Lobby Level

Registration Opens

8:00 am – Lobby Level

One-to-One Meetings 

8:55 am – 2nd Floor

Welcome Back 

  • Sara Jane Demy, Founder & CEO, Demy-Colton

9:00 am – 2nd Floor

“Big Think" Plenary Session  

Adjusting to the New Reality 

Panel: 

  • Cartier Esham, CEO, Esham Strategies
  • Nancy Myers, CEO & Founder, Catalyst Healthcare Consulting 
  • Peter Rubin, Executive Director, No Patient Left Behind 

9:45 am – Lobby Level

One-to-One Meetings

9:45 am – 2nd Floor

Dialogue 3A 

AI: From Target and Lead Discovery to Clinical Trials and Personalized Medicine – Revolutionizing Drug Development 

Panel: 

  • Maria Pineda, CEO & Co-founder, Envisagenics 

9:45 am – 12th Floor

Dialogue 3B

10:50 pm – 2nd Floor

Seed Pitch Doctor Presentations 

12:15 pm – 2nd Floor & Lobby Level

Lunch

1:15 pm – 2nd Floor

“Big Think” Plenary Session 

Venture Investment in Biopharma: Are We Seeing Signs of Recovery?

2:00 pm – 2nd Floor

Closing “Big Think” Plenary Session 

Heard Around the Street: What’s Buzzing in Biopharma       

Moderator:  

  • Virginia Amman, CEO & Founder, ENTENTE Networks 

2:45 pm

Closing Reception

Be a part of BioFuture

© 2024 BioFutureTM. All Rights Reserved

Produced by